secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001104659-25-098725
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar raises ~$5.8M via warrant exercise; prelim cash $12.6M as of Sep 30
-----------------------------------------------------------------------------

- Gross proceeds of ~$5.8M from exercise of 1,048,094 existing warrants at $5.25/share; holders paid $0.125 per new warrant.
- Preliminary cash and equivalents ~$12.6M as of Sep 30, 2025; combined with net proceeds of ~$5.2M, runway extends into Q3 2026.
- Issued Series I warrants (exercisable at $6.00, 5-yr term) and Series II warrants (exercisable at $6.00, 18-mo term) for 100% of exercised shares.
- Company to file a resale registration statement for new warrant shares within 15 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925098725/0001104659-25-098725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925098725/tm2528473d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer